中国先天性心脏病介入治疗器材的研发历程  

History and Development of Interventional Devices for Congenital Heart Diseases in China

作　　者：秦永文[1] 白元[1] QIN Yongwen;BAI Yuan(Department of Cardiology,Changhai Hospital,Shanghai 200433,China)

机构地区：[1]长海医院心血管内科,上海200433

出　　处：《协和医学杂志》2021年第3期309-312,共4页Medical Journal of Peking Union Medical College Hospital

摘　　要：中国先天性心脏病介入治疗器材的研制经历了模仿、改良和创新过程。历经30多年的发展,封堵器的结构和性能均达到了比较完善的水平。临床数十万例应用和长期随访结果证明,国产先天性心脏病介入治疗器材性能稳定、疗效可靠。其中,国产室间隔缺损封堵器的研制和应用处于全球领先水平。近年来的创新型封堵器,如可吸收封堵器的研制和应用也已彰显中国特色,有望在该领域再创辉煌。The development of interventional devices for congenital heart diseases in China has experienced the stage of imitation,improvement and innovation.After more than 30 years of evolution,the structure and performance of the devices made in China have reached a relatively perfect level.The experiences of clinical application and long-term follow-up of hundreds of thousands of cases show that the interventional devices made in China for congenital heart disease have stable performance and reliable curative effect.Among them,the performance of devices made in China for ventricular septal defect is world leading.In recent years,the development and application of innovative occluders,such as absorbable occluders,have also demonstrated Chinese characteristics,and are expected to create brilliant achievements in this field.

关 键 词：先天性心脏病 介入器材 经导管治疗 室间隔缺损 

分 类 号：R541[医药卫生—心血管疾病] R654.2[医药卫生—内科学]